Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
30 studies found for:    " April 06, 2011":" May 06, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" April 06, 2011":" May 06, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Traditional Complementary and Alternative Medicine (CAM) Therapy in the Treatment of HIV/AIDS
Condition: HIV Infections
Intervention: Drug: "Kallunk oxide (Immunotherapy) "
2 Completed Text Messaging Intervention to Improve HIV Adherence in Rural Drug Users
Condition: HIV Infections
Interventions: Behavioral: Text messaging plus EMA;   Behavioral: Treatment as usual
3 Terminated
Has Results
Evaluation of 3TC or FTC Mono-therapy Compared to Continuing HAART as a Bridging Strategy
Condition: HIV Disease
Interventions: Drug: HAART regimen;   Drug: 3TC or FTC monotherapy
4 Withdrawn A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa
Condition: HIV Infections
Interventions: Other: Dapivirine;   Other: Placebo;   Drug: Dapivirine
5 Withdrawn A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa
Condition: HIV Infections
Interventions: Other: Dapivirine;   Other: Placebo;   Drug: Dapivirine
6 Completed
Has Results
Clinical Study of TUTI-16 in Asymptomatic HIV-1 Infected Subjects (THYMON-11001)
Condition: HIV Infections
Interventions: Biological: TUTI-16 (1.0 mg);   Other: Placebo
7 Completed Human Immune Responses Toward HIV-1 Envelope Antigens
Condition: HIV Infection
Intervention:
8 Completed
Has Results
Drug Drug Interaction of BI 201335 and Tenofovir
Condition: HIV Infections
Intervention: Drug: tenofovir/BI 201335
9 Unknown  Effect of a Non-tenofovir, Non-efavirenz-based HIV Regimen on Bone Density and Vitamin D Levels in African-American Patients With HIV Infection
Condition: HIV
Interventions: Drug: atripla;   Drug: darunavir ritonavir raltegravir
10 Completed Single Ascending Dose (SAD)/Multiple Ascending Dose(MAD) Safety/Pharmacokinetic (PK) Study of KM-023
Condition: Human Immunodeficiency Virus
Interventions: Drug: KM-023;   Drug: Placebo for KM-023
11 Completed Treatment Advocacy Intervention for HIV-Positive African Americans
Condition: HIV
Intervention: Behavioral: Treatment Advocacy
12 Completed A Study to Investigate the Pharmacokinetics, Safety and Tolerability of GSK1349572 (Dolutegravir, DTG) in Healthy Japanese Subjects
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: GSK1349572
13 Recruiting Collection of Blood for Multiple Collaborative Studies
Condition: HIV
Intervention:
14 Completed Evaluation of a New HIV Prevention Intervention for Black Bisexually-active Men
Conditions: Bisexually-active Men;   at Risk for HIV
Interventions: Behavioral: RISE life coaching intervention;   Behavioral: HIV Counseling
15 Completed Efficacy and Safety of Two Pharmacologic Strategies on Neurocognitive Impairment in HIV Infection. The TRIANT-TE Study
Conditions: Neurocognitive Disturbance;   HIV Infection
Interventions: Drug: Lithium;   Drug: Rivastigmine
16 Completed Drug Interactions Between Silimarine and Darunavir/Ritonavir
Condition: HIV
Intervention: Drug: Silimarine
17 Completed Antiretroviral Resistance Detection by Ultrasensitive Pyrosequencing of the HIV-1 Genome and Virological Response to Antiretroviral Rescue Treatment
Condition: HIV
Intervention:
18 Active, not recruiting
Has Results
Phase IIIB Study Evaluating the Effects of Atazanavir Powder With Ritonavir in HIV-infected Pediatric Patients
Condition: HIV
Interventions: Drug: Atazanavir Sulphate;   Drug: Ritonavir
19 Completed Efficacy, Safety, and Tolerability of Cenicriviroc (CVC) in Combination With Truvada or Sustiva Plus Truvada in HIV 1-infected, Antiretroviral Treatment-naïve, Adult Patients Infected With Only CCR5-tropic Virus
Condition: HIV-1 Infection
Interventions: Drug: Cenicriviroc 100 mg;   Drug: Cenicriviroc 200 mg + Truvada;   Drug: Sustiva + Truvada
20 Completed
Has Results
Atazanavir/Ritonavir, Once Daily + Raltegravir, Twice Daily, Switch Study in HIV-1—Infected Patients
Condition: HIV, Combination Therapy
Interventions: Drug: Atazanavir;   Drug: Ritonavir (heat-stable);   Drug: Raltegravir;   Drug: Tenofovir/Emtricitabine

   Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.